CS logo
small CS logo
Instituto de Oncologia Angel H. Roffo

Buenos Aires, Argentina
Hospital in Buenos Aires
Av. San Martín 5481, C1417 CABA

About Instituto de Oncologia Angel H. Roffo


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eisai Inc.
1
Janssen-Cilag Ltd.
1
Laboratorio Elea Phoenix S.A.
1
M.D. Anderson Cancer Center
1
NCIC Clinical Trials Group
1
Servier Affaires Médicales
1
Total Rows: 6

Clinical Trials at Instituto de Oncologia Angel H. Roffo


During the past decade, Instituto de Oncologia Angel H. Roffo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11220000Started TrialsCompleted Trails201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
2009-08-25
2024-12-31
Active, not recruiting
137
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients
2009-09-01
2014-06-01
Completed
7
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])
2018-06-11
2024-10-07
Active, not recruiting
827
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
2019-03-08
2024-04-30
Active, not recruiting
1,000
A Registry Study of Participants With Multiple Myeloma in Latin America
2019-05-29
2022-06-30
Completed
2,059

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Instituto de Oncologia Angel H. Roffo" #1 sponsor was "Eisai Inc." with 1 trials, followed by "Janssen-Cilag Ltd." with 1 trials sponsored, "Laboratorio Elea Phoenix S.A." with 1 trials sponsored, "M.D. Anderson Cancer Center" with 1 trials sponsored and "NCIC Clinical Trials Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia Angel H. Roffo" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEisai Inc.: 1Eisai Inc.: 1Janssen-Cilag Ltd.: 1Janssen-Cilag Ltd.: 1Laboratorio Elea Phoenix S.A.: 1Laboratorio Elea Phoenix S.A.: 1M.D. Anderson Cancer Center: 1M.D. Anderson Cancer Center: 1NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1Servier Affaires Médicales: 1Servier Affaires Médicales: 1

Created with Highcharts 11.1.0Top CollaboratorsMerck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1National Cancer Institute (NCI): 1National Cancer Institute (NCI): 1

Clinical Trials Conditions at Instituto de Oncologia Angel H. Roffo


According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia Angel H. Roffo" are "Advanced Non-small Cell Lung Cancer" (1 trials), "Cervical Adenocarcinoma" (1 trials), "Cervical Squamous Cell Carcinoma, Not Otherwise Specified" (1 trials), "Endometrial Neoplasms" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Instituto de Oncologia Angel H. Roffo" in a lesser frequency.

Clinical Trials Intervention Types at Instituto de Oncologia Angel H. Roffo


Most popular intervention types in "Instituto de Oncologia Angel H. Roffo" are "Other" (4 trials), "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Best support treatment" (1 trials), "Doxorubicin" (1 trials), "Lenvatinib" (1 trials), "Lymph Node Mapping" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto de Oncologia Angel H. Roffo


The vast majority of trials in "Instituto de Oncologia Angel H. Roffo" are 4 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Instituto de Oncologia Angel H. Roffo


Currently, there are NaN active trials in "Instituto de Oncologia Angel H. Roffo". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto de Oncologia Angel H. Roffo, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Oncologia Angel H. Roffo, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Completed: 3Completed: 3